Skip to content

Clinical trials

Bronchial Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchial Neoplasms Country / region: France Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20174
20191
20213
20221
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Active, not recruiting3
Completed3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Revolution Medicines, Inc.3
ArriVent BioPharma, Inc.1
AstraZeneca1
Blueprint Medicines Corporation1
Centre Henri Becquerel1
Hoffmann-La Roche1
Iovance Biotherapeutics, Inc.1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchial Neoplasms13
Carcinoma, Non-Small-Cell Lung13
Lung Neoplasms12
Lung Diseases11
Respiratory Tract Neoplasms11
Neoplasms by Site10
Respiratory Tract Diseases10
Neoplasms9
Thoracic Neoplasms9
Carcinoma, Bronchogenic7

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.